Low-grade serous - rare tumorMEK inhibitorOvarian cancerPURPOSE OF REVIEW:This review provides an overview of the current clinical standard in low-grade serous ovarian cancer (LGSOC). The available evidence for surgery and standard treatments is elaborated. In addition, we discuss recent findings ...
NRG1 Fusions Hold Promise as Pan-tumor Target CAR T-Cell Research Surges French Study Sheds Light on COVID-19 Stress Among Patients With Cancer Uncovering TP53 Mutations in MDS, AML Requires NGS First Nonoperative Option Arrives for Low-Grade UTUC Radiation Oncology Leaders Bristle Over New Medic...
The authors describe three patients with low grade B-cell lymphoproliferative disease who developed subsequent indeterminate cell or interdigitating cell tumors. When the two cases of indeterminate cell tumor are added to those previously described in the literature, it appears that 4 of 13 cases (...
BC is classified as low-grade (LG) and high-grade (HG) tumors based on the degree by which cancer cells histologically differ from normal bladder cells. LG BC has a low risk of recurrence and progression, whereas HG BC is frequently associated with tumor recurrence and progression to ...
Wu CJ, Wang Q, Li H, Wang XN, Liu XS, Shi HB, Zhang YD. DWI-associated entire-tumor histogram analysis for the differentiation of low-grade prostate cancer from intermediate-high-grade prostate cancer. Abdom Imaging. 2015;40(8):3214-21....
Moreover, CXCL10 is expressed in basal tumors as compared with ER+ tumors, being associated with a higher tumor grade and a poor prognosis of breast cancer42. On the other hand, miRNAs play critical regulatory roles in a wide range of biologic and pathologic processes, and miRNA ...
For each avoided transurethral bladder tumor resection, the average specific annual resource consumption savings was €1,378. "Active surveillance might be a reasonable clinical and cost-effective strategy in patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors," the...
[97]. Importantly,KRASmutations are also seen in high grade gliomas and therefore cannot be used as a diagnostic marker for pLGG. Given the success of inhibiting downstream effectors ofKRASmutations in other cancer types [74], identifying these mutations in pLGG may offer access to targeted ...
Absence of pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) correlates with poor long-term survival in patients with triple negative breast cancer (TNBC). These incomplete treatment responses are likely determined by mechanisms that
pylori infection, thereby promoting the activation status of the lymphocytic infiltrate in low-grade MALT lymphoma, or may mirror a concomitant tumor-specific T-cell response accompanying early stages of tumor progression. 展开 年份: 2001 收藏 引用 批量引用 报错 分享 ...